SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-126912
Filing Date
2023-04-28
Accepted
2023-04-28 16:08:00
Documents
18
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d504496ddef14a.htm DEF 14A 714299
2 GRAPHIC g504496g01a50.jpg GRAPHIC 123795
3 GRAPHIC g504496g02b50.jpg GRAPHIC 119608
4 GRAPHIC g504496g03i97.jpg GRAPHIC 47599
5 GRAPHIC g504496g08r90.jpg GRAPHIC 1929
6 GRAPHIC g504496g10u19.jpg GRAPHIC 1566
7 GRAPHIC g504496g18p42.jpg GRAPHIC 1835
8 GRAPHIC g504496g24x78.jpg GRAPHIC 44800
9 GRAPHIC g504496g25o84.jpg GRAPHIC 17266
10 GRAPHIC g504496g28m20.jpg GRAPHIC 83052
11 GRAPHIC g504496g41n61.jpg GRAPHIC 2966
12 GRAPHIC g504496g44a18.jpg GRAPHIC 2885
13 GRAPHIC g504496g64n32.jpg GRAPHIC 23074
14 GRAPHIC g504496g74j99.jpg GRAPHIC 7221
15 GRAPHIC g504496g78p87.jpg GRAPHIC 1128
16 GRAPHIC g504496g80e61.jpg GRAPHIC 56826
17 GRAPHIC g504496g83x67.jpg GRAPHIC 1944
18 GRAPHIC g504496g86t40.jpg GRAPHIC 19686
  Complete submission text file 0001193125-23-126912.txt   1485256
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 23866054
SIC: 2834 Pharmaceutical Preparations